Clinically relevant characterization of lung adenocarcinoma subtypes based on cellular pathways: an international validation study.
about
Role of molecular studies in the diagnosis of lung adenocarcinomaInternational association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinomaDifferential pathogenesis of lung adenocarcinoma subtypes involving sequence mutations, copy number, chromosomal instability, and methylationA simple but highly effective approach to evaluate the prognostic performance of gene expression signaturesPersonalized identification of altered pathways in cancer using accumulated normal tissue data.CHK1 levels correlate with sensitization to pemetrexed by CHK1 inhibitors in non-small cell lung cancer cellsLung adenocarcinoma subtypes based on expression of human airway basal cell genesRelation between smoking history and gene expression profiles in lung adenocarcinomasA pilot characterization of human lung NSCLC by protein pathway activation mapping.ASCL1 and RET expression defines a clinically relevant subgroup of lung adenocarcinoma characterized by neuroendocrine differentiation.SPARCoC: a new framework for molecular pattern discovery and cancer gene identificationA grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma.Solid Predominant Histologic Subtype in Resected Stage I Lung Adenocarcinoma Is an Independent Predictor of Early, Extrathoracic, Multisite Recurrence and of Poor Postrecurrence SurvivalThe HSP90 Inhibitor Ganetespib Radiosensitizes Human Lung Adenocarcinoma Cells.The evolving role of the pathologist in the management of lung cancer.Histologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcome.Expression of Ribonucleotide Reductase Subunit-2 and Thymidylate Synthase Correlates with Poor Prognosis in Patients with Resected Stages I-III Non-Small Cell Lung Cancer.Glyceraldehyde-3-phosphate dehydrogenase gene over expression correlates with poor prognosis in non small cell lung cancer patientsCheckpoint kinase 1 protein expression indicates sensitization to therapy by checkpoint kinase 1 inhibition in non-small cell lung cancer.Histological specificity of alterations and expression of KIT and KITLG in non-small cell lung carcinoma.eMBI: Boosting Gene Expression-based Clustering for Cancer Subtypes.Intrinsic cancer subtypes-next steps into personalized medicine
P2860
Q27023212-68703260-2A6D-4F16-8FD3-3E2FEFC24039Q28303718-52C1441F-E683-424C-83D0-3D0EB8A45F60Q28730029-2567AA00-6EDF-4CCF-BBB1-D2AD7C72C71DQ28741755-796E5075-4DBF-46F1-8300-70E2D9C6B51DQ30366103-4309333E-1838-4C49-8323-F0FFA4F50B26Q33815609-B1A08651-6F0D-4B4B-915E-6B5B1C53623AQ34013536-9158966E-29AA-4111-A1B9-EED13F4BC8F4Q34296059-03378F38-73B5-47B4-970D-D556DFD97CE9Q34478770-820711F1-A96F-4932-B335-B3CD8373053DQ35087767-755152B0-C1E4-4EF1-AF02-DA03E86FBD9EQ35175659-57633AB1-1D28-4FEE-9C9E-A222AB55E52FQ35245367-D1BFCEB0-241D-4F4E-8027-1E6C3305DB36Q35742165-776DEC76-3CC8-41FF-A09A-BBD76EE5D7F2Q35818450-BD58F8AC-D9EC-4B1C-B9A2-DB55A57A82C9Q35951079-2F69D0B0-BD09-45E5-96F6-FABADF6C8B31Q36013991-62B9DF34-D69A-4609-97E7-68B4B6A73590Q36333164-7BF9E706-343C-43E2-8640-A6C2DEC148ACQ37153528-2AA4A284-635B-4E8C-B444-69F232533085Q39034833-BD74A165-FFA6-4F30-AEAA-EC2B3A73C6C2Q39353163-ECE411DC-39F6-4430-8C2B-A6DCCBBCB1AAQ42967077-7CA64DEB-1FBF-40A0-AE3A-A626ECA66895Q58053534-8DACDEF1-7790-4476-8313-ECF0762CD970
P2860
Clinically relevant characterization of lung adenocarcinoma subtypes based on cellular pathways: an international validation study.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Clinically relevant characteri ...... nternational validation study.
@ast
Clinically relevant characteri ...... nternational validation study.
@en
type
label
Clinically relevant characteri ...... nternational validation study.
@ast
Clinically relevant characteri ...... nternational validation study.
@en
prefLabel
Clinically relevant characteri ...... nternational validation study.
@ast
Clinically relevant characteri ...... nternational validation study.
@en
P2093
P2860
P50
P1433
P1476
Clinically relevant characteri ...... nternational validation study.
@en
P2093
Chinatsu Arima
Christian Brambilla
Christopher M Bryant
Daniel L Albertus
David G Beer
Guoan Chen
Mickael Guedj
William D Travis
P2860
P304
P356
10.1371/JOURNAL.PONE.0011712
P407
P577
2010-07-22T00:00:00Z